Neuvasq
3 known investors
Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders. The company translates research on brain vasculature and the blood-brain barrier into drug development programs.
Founders & leadership
Investors · 3
Frequently asked questions
- What does Neuvasq do?
- Neuvasq Biotechnologies is a biotech spin-off from the Université libre de Bruxelles developing therapies that target the Gpr124/Reck signaling complex to repair the blood-brain and blood-CNS barriers in neurological and cerebrovascular disorders. The company translates research on brain vasculature and the blood-brain barrier into drug development programs.
- Who founded Neuvasq?
- Neuvasq was founded by Benoit Vanhollebeke.
- Who are Neuvasq's investors?
- Neuvasq's investors include Newton Biocapital, Sambrinvest, Wallonie Entreprendre.